Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GSK publishes Annual Report 2023

1 Mar 2024 12:15

RNS Number : 2981F
GSK PLC
01 March 2024
 

 

GSK plc

(the 'Company')

 

Publication of Annual Report 2023

 

 

The Company has today published on its website www.annualreport.gsk.com its Annual Report for the year ended 31 December 2023 ('Annual Report 2023').

 

In compliance with Listing Rule 9.6.1R of the UK Financial Conduct Authority ('FCA'), the Annual Report 2023 has been submitted to the FCA's National Storage Mechanism ('NSM') and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

A hard copy version of the Annual Report 2023 and the Notice of Annual General Meeting 2024 ('AGM Notice') will be sent to those shareholders who have elected to receive paper communications on or around 25 March 2024. The AGM Notice will be made available to shareholders who have not elected to receive paper communications on the same date.

 

This announcement is not a substitute for reading the Annual Report 2023 in full.

 

Additional Information

 

For the purposes of complying with the FCA's Disclosure and Transparency Rules ('DTRs') and the requirements imposed on issuers through the DTRs, information required to be communicated with the media in unedited full text was included in the Annual Report 2023. The Annual Report 2023 was submitted to the NSM and will shortly be available for inspection. It is also available on the Company's website as noted above.

 

This announcement is made in accordance with DTR 6.3.5R(1A).

 

V A Whyte

Company Secretary

 

1 March 2024

 

?

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSEAADFEFALEFA
Date   Source Headline
14th Jan 20204:01 pmRNSDirector/PDMR Shareholding
13th Jan 20206:00 pmRNSDirector/PDMR Shareholding
13th Jan 202011:41 amRNSDirector/PDMR Shareholding
13th Jan 202011:01 amRNSDirector/PDMR Shareholding
13th Jan 202010:34 amRNSDirector/PDMR Shareholding
8th Jan 20204:30 pmRNSGSK publishes provisional 2020 Dividend Dates
8th Jan 20203:11 pmRNSGSK publishes 2020 Dividend Dates
8th Jan 20202:37 pmRNSGSK Announces addition to Corporate Executive Team
2nd Jan 20209:58 amRNSTotal Voting Rights
23rd Dec 20197:01 amRNSViiV Healthcare receives complete response letter
18th Dec 20195:12 pmRNSDirector/PDMR Shareholding
18th Dec 20194:55 pmRNSDirector/PDMR Shareholding
17th Dec 20199:00 amRNSBlocklisting Application
13th Dec 20194:48 pmRNSDirector/PDMR Shareholding
11th Dec 20194:57 pmRNSDirector/PDMR Shareholding
5th Dec 201912:00 pmRNSViiV submits NDA to FDA for fostemsavir
4th Dec 20195:34 pmRNSEmma Walmsley - External Appointment
2nd Dec 20195:52 pmRNSDirector/PDMR Shareholding
2nd Dec 20194:54 pmRNSTotal Voting Rights
26th Nov 20193:00 pmRNSBlock listing Interim Review
12th Nov 20193:51 pmRNSDirector/PDMR Shareholding
8th Nov 20194:22 pmRNSDirector/PDMR Shareholding
6th Nov 20194:36 pmRNSDirector/PDMR Shareholding
4th Nov 20195:35 pmRNSDirector/PDMR Shareholding
1st Nov 20195:19 pmRNSDirector/PDMR Shareholding
1st Nov 20199:53 amRNSTotal Voting Rights
31st Oct 20191:34 pmRNSDirector/PDMR Shareholding
30th Oct 20195:32 pmRNSDirector/PDMR Shareholding
30th Oct 201912:07 pmRNSSecond Price Monitoring Extn
30th Oct 201912:02 pmRNSPrice Monitoring Extension
30th Oct 201912:00 pmRNS3rd Quarter Results
21st Oct 20198:00 amRNSGSK divests two travel vaccines to Bavarian Nordic
15th Oct 20195:00 pmRNSDirector/PDMR Shareholding
15th Oct 20195:00 pmRNSDirector/PDMR Shareholding
15th Oct 20195:00 pmRNSDirector/PDMR Shareholding
15th Oct 20195:00 pmRNSDirector/PDMR Shareholding
11th Oct 20195:34 pmRNSDirector/PDMR Shareholding
11th Oct 20194:10 pmRNSDirector/PDMR Shareholding
10th Oct 20194:18 pmRNSDirector/PDMR Shareholding
1st Oct 20196:18 pmRNSDirector/PDMR Shareholding
1st Oct 20191:09 pmRNSTotal Voting Rights
30th Sep 20197:00 amRNSPRIMA shows Zejula improves PFS in ovarian cancer
30th Sep 20197:00 amRNSData show anti-tumour activity with ICOS agonist
26th Sep 20196:26 pmRNSDirector/PDMR Shareholding
17th Sep 20195:46 pmRNSDirector/PDMR Shareholding
11th Sep 20194:30 pmRNSDirector/PDMR Shareholding
4th Sep 20195:37 pmRNSDirector/PDMR Shareholding
4th Sep 201912:36 pmRNSDirector/PDMR Shareholding
4th Sep 20199:33 amRNSDirector/PDMR Shareholding
2nd Sep 201911:29 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.